Researchers have demonstrated that self-sampling is just as effective as speculum-based testing for HPV detection.
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback